• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 59,086.00
    1,312.35 (+2.27%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,953.95(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,427.75 1,013.95(%)
  • M & M
    3,295.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    787.00 1,017.90(%)
  • ICICI Bank
    1,569.30 1,569.30(%)
  • Sai Life
    1,815.55 1,815.55(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,323.90 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,118.90 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,318.10 1,611.20(%)
  • SBI
    1,020.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astal Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4277.0
  • ISIN : INE307N01014
60.39 0 (0.17%)
  • As on 07 Nov 2026 (EOD)

  • Today’s Low

    59.50

  • Today’s High

    61.50

  • Open

    60.36

  • Perv Close

    60.29

  • 52W Low

    49.99

  • 52W High

    99.90

Key Indicators

  • P/E(TTM)

    27.20

  • Mar.Cap (₹Cr.)

    264.50

  • Div & Yield %

    0.00

  • Book Value(₹)

    75.67

  • Debt-Equity Ratio

    0.17

  • AGM Date

    06-Nov-2026

  • EPS

    2.22

  • P/E Ratio

    27.20

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    264.50

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    43.80

  • BV (₹)

    75.70

  • Sales( ₹ in Cr.)

    156.00

  • NP (in Cr.)

    8.12

  • NP Var(%)

    -9.0

  • Div%

    0.0

  • CPS (₹)

    2.00

  • EPS (₹)

    1.90

  • Traded Value (₹ in Lakhs)

    264.50

  • 52 Week High

    99.90

  • 52 Week Low

    49.99

  • Price BSE

    60.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    264.50

  • P/C Ratio

    29.80

  • P/E Ratio

    32.40

  • Price Vs.BV

    1.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 156.00 64.23 23.65 3.43 0.00 0.20
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 156.00 64.23 23.65 3.43 0.00 0.20
Other Income 0.19 0.13 0.01 0.18 0.21 0.00
Stock Adjustments 14.02 13.70 1.06 0.00 0.00 0.00
Total Income 170.21 78.06 24.72 3.61 0.21 0.20
EXPENDITURE :            
Raw Materials 152.88 61.81 22.40 3.35 0.00 0.00
Power and Fuel Cost 0.28 0.14 0.02 0.01 0.02 0.01
Employee Cost 2.12 1.26 0.47 0.06 0.09 0.06
Other Manufacturing Expenses 0.25 0.37 0.00 0.01 0.01 0.01
Selling and Administration Expenses 1.70 1.57 0.71 0.13 0.10 0.10
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.01 0.00
Employee Benefit Expenses 2.12 1.26 0.47 0.06 0.09 0.06
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 157.23 65.15 23.59 3.56 0.21 0.18
Operating Profit 12.96 12.90 1.13 0.04 0.00 0.02
Interest 1.41 0.70 0.01 0.00 0.00 0.00
Gross Profit 11.55 12.20 1.12 0.04 0.00 0.02
Depreciation 0.69 0.22 0.03 0.01 0.01 0.02
Profit Before Tax 10.86 11.98 1.09 0.03 -0.01 0.00
Current Tax 2.59 2.94 0.29 0.01 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.16 0.11 0.01 0.01 0.00 0.00
Reported Net Profit 8.12 8.93 0.78 0.02 -0.02 0.01
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 8.12 8.93 0.78 0.02 -0.02 0.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 10.70 1.78 0.99 0.98 0.99 0.99
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 18.82 10.70 1.78 0.99 0.98 0.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.92 9.07 0.80 0.04 -0.04 0.02
Earnings Per Share(Adj)-Unit Curr 1.92 9.07 0.80 0.04 -0.04 0.02
Book Value 76.98 32.77 23.71 12.98 12.93 12.97
Book Value(Adj)-Unit Curr 76.98 32.77 23.71 12.98 12.93 12.97

Shareholding Pattern

  • Promoter Group

    4.59%

  • Public Share Holding

    95.41%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,011,027 4.59 2,011,027 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,011,027 4.59 2,011,027 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,184,617 2.70 1,147,417 25
Clearing Members 248 0.00 248 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 4,101,658 9.36 4,101,658 36
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 729,744 1.67 729,744 51
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 32,252,461 73.64 32,252,461 165
Individuals holding nominal share capital up to Rs. 1 lakh 3,236,242 7.39 2,880,622 3,066
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 41,787,905 95.41 41,395,085 3,350
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 43,798,932 100.00 43,406,112 3,351

Company Background

Astal Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Astal Laboratories Ltd
  • BSE Code : 4277.0
  • ISIN : INE307N01014

  • Incorporation Year

    1993

  • Registered Office

    House No 4-50/1 Sy No 134 132
    Block B 8th Floor Flat No 801, Hyderabad,
    Telangana-500032

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Mahendra Kumar

  • Auditor

    Sathuluri & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.&Computer Ser.P Ltd
    99 BeetalHouse 3rd F,
    Behind Local Shp Cen,Nr Dada Harsukh Das
    Mumbai - New Delhi - 110062

Astal Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astal Lab 60.39 156.19 156.00 27.20 6.31
Abbott India 26,340.05 7,217.19 6,929.05 34.66 43.78
Astrazeneca Phar 6,387.90 2,304.07 2,275.58 94.15 27.86
Glaxosmi. Pharma 2,524.85 3,932.76 3,790.20 37.52 58.17
Evonile Pharma 1,762.40 393.10 354.33 -1,087.90 15.94
Cipla 1,409.00 20,102.60 18,979.95 42.94 13.88
Bliss GVS Pharma 603.40 773.53 729.81 39.34 12.51
Amrutanjan Healt 513.30 520.13 502.55 25.90 24.16
Fermenta Biotec. 447.05 474.15 450.25 20.87 18.77
Guj. Themis Bio. 379.05 168.25 165.82 101.35 18.05
Ambalal Sarabhai 35.25 19.52 3.94 65.28 6.77